Crossmark

Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study

Crossref DOI link: https://doi.org/10.1186/s12933-022-01685-4

Published Online: 2022-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chyrchel, Bernadeta

Kruszelnicka, Olga

Surdacki, Andrzej
Funding

Funding for this research was provided by:

Jagiellonian University Medical College, Cracow, Poland (N41/DBS/000032; N41/DBS/000665; K/ZDS/006104, K/ZDS/003761; K/ZDS/006105)
License Information

Text and Data Mining valid from 2022-11-17

Version of Record valid from 2022-11-17
More Information

Article History

Received: 1 October 2022

Accepted: 3 November 2022

First Online: 17 November 2022

Declarations

:

: The study protocol was approved by the Bioethical Committee of our university (Approval numbers: KBET/277/B/2013 and 1072.6120.143.2019 issued on November 28th, 2013 and May 30th, 2019, respectively) and written informed consent was obtained from the study subjects.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below